inflammation and glp 1 GLP-1 Receptor Agonists in Chronic Inflammatory Skin Diseases: Immunometabolic Mechanisms Translational Perspectives The Interplay Between GLP-1-Based Therapies,

The concentration of glutathione is crucialaim for products with at least 0.5% glutathione content, though some effective formulations go up to 2-3%

For best results, take a high quality probiotic with multiple strains of beneficial bacteria

GLP-1 side effects should be discussed with a doctor when nausea, constipation, vomiting, reflux, fatigue, dizziness, abdominal pain, dehydration, or poor intake interferes with daily life, prevents the patient from eating enough protein or drinking enough fluid, worsens after a dose increase, persists for more than a short adjustment period, or feels severe or unusual

PubMed DOI Schagen SK (2017)

Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, et al